A quiet problem has followed cancer immunotherapy for years. The immune system can be taught to fight, then it fades.

Immune Checkpoint Blockade (ICB) has revolutionized the treatment of cancers like melanoma, but up to 60% of patients don't ...

The Union minister said immunotherapy services are being provided at select tertiary-level government hospitals equipped with necessary infrastructure, trained specialists and approved drugs ...

A lung cancer trial bolsters a long-held idea that treatment timing matters, showing a simple shift could help immunotherapy ...

Detailed price information for Lixte Biotech Hlds (LIXT-Q) from The Globe and Mail including charting and trades.

The BBVA Foundation Frontiers of Knowledge Award in Biology and Biomedicine has gone in this eighteenth edition to Carl June ...

New research suggests cancer immunotherapy may work better when given earlier in the day. In a randomized lung cancer study, ...

Despite demonstrating a significant survival advantage in the first-line treatment of unresectable hepatocellular carcinoma (HCC), the combination of nivolumab (Opdivo) and ipilimumab (Yervoy) is ...

New Members Bring Expertise in Immunology, Genomics, Clinical Oncology, and Patient Advocacy to Guide LCFA's Research Investments and Accelerate Breakthroughs ...

A large database analysis finds that survival differences between men and women with metastatic melanoma disappear when ...

Researchers have uncovered the mechanisms behind three unique subtypes of mismatch repair deficient high-grade gliomas. The ...

The American Society of Hematology (ASH) has published new clinical practice guidelines for the management of acute lymphocytic leukemia (ALL) in adolescents and young adults (AYAs). 1 ...